Pancreatic exocrine insufficiency in patients who have undergone surgery due to pancreatic cancer: A cost-utility analysis

被引：0
|
作者：
Kim, Hansoo [1 ]
Byrnes, Joshua [1 ]
Kim, Kyoo [2 ]
Fragkogianni, Dafni [2 ]
Roberts, Keith [3 ]
Lee, Sang Hyub [4 ]
机构：
[1] Griffith Univ, Nathan, Qld, Australia
[2] Abbott Prod Operat AG, Allschwil, Switzerland
[3] Univ Birmingham, Birmingham, W Midlands, England
[4] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
pancreatic exocrine insufficiency (PEI); pancreatic enzyme replacement; therapy (PERT); pancreatic cancer; pancreatic resection; cost-utility analysis;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
No. 0494
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [41] An analysis on fat digestion in the upper small intestine and the effect of pancreatic enzyme substitution in patients with exocrine pancreatic insufficiency
    Yamada, N
    Nakamura, T
    Tando, Y
    Arai, Y
    Terada, A
    Suda, T
    [J]. 2ND WORLD CONGRESS - INTERNATIONAL HEPATO-PANCREATO-BILIARY ASSOCIATION, VOL II: BILIARY-PANCREAS, 1996, : 1061 - 1064
  • [42] Efficacy of a Novel Pancreatic Enzyme Product, EUR-1008 (Zenpep), in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis
    Toskes, Phillip P.
    Secci, Angelo
    Thieroff-Ekerdt, Ruth
    [J]. PANCREAS, 2011, 40 (03) : 376 - 382
  • [43] Cost-utility analysis of aprepitant for patients who truly need it in Japan
    Tsukiyama, Ikuto
    Ando, Masahiko
    Tsukiyama, Sumiyo
    Takeuchi, Masayuki
    Ejiri, Masayuki
    Kurose, Yusuke
    Saito, Hiroko
    Arakawa, Ichiro
    Inoue, Tadao
    Yamaguchi, Etsuro
    Kubo, Akihito
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (10) : 3749 - 3758
  • [44] Cost-utility analysis of aprepitant for patients who truly need it in Japan
    Ikuto Tsukiyama
    Masahiko Ando
    Sumiyo Tsukiyama
    Masayuki Takeuchi
    Masayuki Ejiri
    Yusuke Kurose
    Hiroko Saito
    Ichiro Arakawa
    Tadao Inoue
    Etsuro Yamaguchi
    Akihito Kubo
    [J]. Supportive Care in Cancer, 2019, 27 : 3749 - 3758
  • [45] DIAGNOSIS OF PANCREATIC EXOCRINE INSUFFICIENCY IN CHRONIC PANCREATITIS, PANCREATIC CANCER AND GASTROINTESTINAL OR PANCREATIC SURGERY PATIENTS: A SYSTEMATIC LITERATURE REVIEW AND EXPERT CONSENSUS ON THE ACCURACY OF DIAGNOSTIC TEST USED IN SPAIN
    De Madaria, E.
    Gonzalez-Carro, P.
    Boadas, J.
    Puig de la Bellacasa, J.
    Carr, E.
    Labrador, E.
    Paz, S.
    Lizan, L.
    Schwander, B.
    Dominguez Munoz, E.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A493 - A493
  • [46] Does surgery still have a role in the management of patients with severe esophagitis? A new cost-utility analysis
    Arguedas, MR
    Heudebert, GR
    Eloubeidi, M
    Wilcox, CM
    Centor, RM
    Spechler, SJ
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A66 - A66
  • [47] Cost-Utility Analysis of Surgical and Endoscopic Management of Pancreatic Walled-Off Necrosis
    Chiang, Austin L.
    Tapper, Elliot B.
    Thompson, Christopher C.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S209 - S210
  • [48] Prevalence of cancer and alcohol use in patients with exocrine pancreatic insufficiency compared to patients with cystic fibrosis
    Peeples, James
    Gore, James
    Romo, Karina G.
    Noor, Abdullah A.
    Uwaifo, Gabriel I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 680 - 680
  • [49] A COST-UTILITY ANALYSIS OF NAB-PACLITAXEL (ABRAXANE) PLUS GEMCITABINE IN METASTATIC PANCREATIC CANCER IN SLOVAK REPUBLIC
    Stetka, R.
    Ondrusova, M.
    Psenkova, M.
    Pastorek, T.
    Salek, T.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A464 - A464
  • [50] COST-UTILITY ANALYSIS OF LAPAROSCOPIC VERSUS OPEN SURGERY FOR COLORECTAL CANCER
    Callejo, D.
    Guerra, M.
    Reza, M.
    Maeso, S.
    Blasco, J. A.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A263 - A263
12345